Search Results for 'treatment of peripheral artery disease'

Back in the day, there was nothing quite like a jobs announcement to get the blood flowing in a journalist. A jobs announcement meant a call from the hallowed offices of the IDA; a tip off that there was good news in the air; an early morning start to meet a Minister on his/her arrival at said destination; wellies at the ready if it was a greenfield plan; or surgical scrubs and hairnets if it was in one of those new squeaky clean facilities that now dominate our industrial landscape.

Medtronic plc, a global leader in medical technology, services and solutions, this week announced a new manufacturing facility in Galway that will manufacture the market-leading IN.PACT® Admiral® drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD). PAD is a build-up of plaque in arteries throughout the body leading to reduced blood flow to the limbs, organs, and the brain. Patients with PAD are at higher risk for stroke and heart attack.

Global medical technology company Medtronic’s has announced it will construct a new manufacturing facility in Galway, that will manufacture the IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease.